XBiotech: Phase II Study Failed to Meet Primary Endpoint Amid Substantial Irregularities That Make Unequivocal Interpretation of Findings Difficult
XBiotech:第二階段研究未能達到主要終點,因存在重大不規則,使結果的明確解釋變得困難
XBiotech: Phase II Study Failed to Meet Primary Endpoint Amid Substantial Irregularities That Make Unequivocal Interpretation of Findings Difficult
XBiotech:第二階段研究未能達到主要終點,因存在重大不規則,使結果的明確解釋變得困難
譯文內容由第三人軟體翻譯。